Telomir Pharmaceuticals Inc. Company Profile
NASDAQ: TELOHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Telomir Pharmaceuticals at a glance
Telomir Pharmaceuticals Inc. (NASDAQ: TELO) is a Biotechnology company in the Healthcare sector headquartered in Miami, FL. Telomir Pharmaceuticals is led by Mr. Erez Aminov. The company's shares have traded publicly since 2024.
At a market capitalization of $84.7 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001971532, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Telomir Pharmaceuticals do?
Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Wilson's disease, Type 2 diabetes, age-related macular degeneration (AMD), oncology, and epigenetic regulation, as well as Alzheimer's disease and Progeria. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. in October 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Miami, Florida.
Business description based on the company's public filings.
Company information
- Legal name
- Telomir Pharmaceuticals Inc.
- Ticker
- NASDAQ: TELO
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Erez Aminov
- Headquarters
- 100 SE 2nd Street, Miami, FL, United States
- Phone
- 786 396 6723
- Website
- telomirpharma.com
- IPO year
- 2024
- Market cap
- $84.66M
- SEC CIK
- 0001971532
Companies similar to Telomir Pharmaceuticals
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NRXSNeuraxis Inc. | 6.77 | -0.88% | $85.02M | vs TELO |
| CGTXCognition Therapeutics Inc. | 0.8952 | -4.42% | $85.13M | vs TELO |
| CRDFCardiff Oncology Inc. | 1.06 | -2.75% | $82.46M | vs TELO |
| PMNProMIS Neurosciences Inc. | 9.15 | +0.33% | $82.05M | vs TELO |
| ICCCImmuCell Corporation | 9.75 | +0.62% | $88.55M | vs TELO |
| MISTMilestone Pharmaceuticals Inc. | 0.7121 | -5.96% | $88.66M | vs TELO |
| ACRVAcrivon Therapeutics Inc. | 1.87 | -0.53% | $80.14M | vs TELO |
| NMRANeumora Therapeutics Inc. | 0.4798 | +2.46% | $90.15M | vs TELO |